Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:41 AM
Ignite Modification Date:
2025-12-25 @ 10:52 PM
NCT ID:
NCT01421667
Group ID:
EG000
Title:
CD30+ NHL (T-Cell and B-Cell), BV
Description:
Brentuximab vedotin (BV) 1.8 mg/kg every 3 weeks by intravenous (IV) infusion in patients in with CD30-positive non-Hodgkin lymphomas (NHL), including T-cell lymphomas and B-cell lymphomas, as well as diffuse large B-cell lymphoma (DLBCL)
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
49
Serious Number At Risk:
103
Other Number Affected:
96
Other Number At Risk:
103
Study:
NCT01421667
Results Section:
NCT01421667
Adverse Events Module:
NCT01421667